Skip to content
healthcare.dev
Get a free key

Darzalex Faspro

NDC 57894-503, daratumumab and hyaluronidase-fihj (human recombinant), injection, from Janssen Biotech, Inc..

Product NDC
57894-503
Status
Listed
Labeler
Janssen Biotech, Inc.
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761145
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57894-503 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DARATUMUMAB1800 mg/15mL
  • HYALURONIDASE (HUMAN RECOMBINANT)30000 U/15mL

Pharmacologic classes

Antibodies, Monoclonal [CS]; CD38-directed Antibody Interactions [MoA]; CD38-directed Cytolytic Antibody [EPC]; Endoglycosidase [EPC]; Glycoside Hydrolases [CS]

Package NDCNDC-11Package
57894-503-01578940503011 VIAL, SINGLE-DOSE in 1 BOX (57894-503-01) / 15 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4bb241af-4299-4373-8762-2d6709515db0

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=57894-503

Use it

Look up 57894-503 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57894-503 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57894-503. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.